Keyphrases
Estrogen
100%
Congestive Heart Failure
100%
Apoptosis Inhibition
100%
Signaling Kinases
100%
Apoptosis
33%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
33%
Cardiomyocytes
33%
Rac1
33%
C-Jun N-terminal Kinase
33%
Nicotinamide Adenine Dinucleotide Phosphate Oxidase
33%
Oxidase Activity
33%
Thioredoxin
33%
Apoptosis Signal-regulating Kinase 1 (ASK1)
33%
Placebo
16%
Angiotensin II (Ang II)
16%
Transgenic
16%
Epidemiological Study
16%
Gender Differences
16%
Cardioprotection
16%
Induced Apoptosis
16%
Cardiac Hypertrophy
16%
17-estradiol
16%
Cardiomyocyte Apoptosis
16%
Contractility
16%
Anti-apoptosis
16%
Adjunctive Therapy
16%
Downstream Effectors
16%
Antioxidant Properties
16%
Antioxidative Mechanism
16%
Superoxide Anion Production
16%
Cardiac Dilation
16%
ICI 182,780
16%
Thioredoxin Reductase Inhibitor
16%
Thioredoxin Reductase
16%
Estrogen Receptor Antagonist
16%
Azelaic Acid
16%
Thioredoxin Reductase Activity
16%
Biochemistry, Genetics and Molecular Biology
Kinase
100%
Phosphotransferase
100%
Programmed Cell Death
100%
Cardiac Muscle Cell
42%
Thioredoxin Reductase
42%
Oxidoreductase
28%
Nicotinamide Adenine Dinucleotide Phosphate
28%
N-Terminus
28%
Oxidase
28%
P38 Mitogen-Activated Protein Kinases
28%
Thioredoxin
28%
Upregulation
14%
Downregulation
14%
Transgenics
14%
Receptor Antagonist
14%
Estrogen Receptor
14%
Muscle Contractility
14%
Angiotensin
14%
Estradiol
14%
Sex Differences
14%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Congestive Heart Failure
100%
Thioredoxin Reductase
50%
Antioxidant
33%
Oxidoreductase
33%
Nicotinamide Adenine Dinucleotide Phosphate
33%
Thioredoxin
33%
Mitogen Activated Protein Kinase P38
33%
Apoptosis Signal Regulating Kinase 1
33%
Placebo
16%
Antiapoptotic
16%
Angiotensin II
16%
Diethylstilbestrol
16%
Superoxide
16%
Heart Ventricle Hypertrophy
16%
Estrogen Receptor Antagonist
16%
Azelaic Acid
16%